Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Docetaxel nanoformulation - NanOlogy

Next Previous
Search
Drug Profile

Docetaxel nanoformulation - NanOlogy

Alternative Names: Large Surface Area Microparticle Docetaxel-NanOlogy; LSAM-docetaxel; LSAM-DTX; NanoDoce

Latest Information Update: 28 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NanOlogy
  • Developer NanOlogy; US Biotest Inc
  • Class Antineoplastics; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • Phase I/II Bladder cancer
  • No development reported Renal cancer

Most Recent Events

  • 28 Jul 2024 No recent reports of development identified for preclinical development in Renal-cancer in USA (Intratumoural, Injection)
  • 19 Dec 2023 Pharmacodynamics data from preclinical trials in Solid tumours released by NanOlogy
  • 07 Mar 2023 NanOlogy has patent protection for Intratumoral administration of LSAM taxanes in combination with systemic administration of immune checkpoint inhibitors (ICIs) in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top